We are looking for individuals with Primary Biliary Cholangitis (PBC) who may be interested in participating in an upcoming Phase 3 clinical research study evaluating a potential new treatment option.

The study will evaluate the efficacy, safety, and tolerability of Nor-UDCA compared with UDCA for the management of PBC.

Why Participate?

By participating in clinical research, you can help researchers learn more about potential treatment options for PBC and contribute to the advancement of future therapies.

Interested in learning more? Contact our research team to see if you may qualify for this study.